Calculation of practical skin donor area for meshed skin grafting in real-world surgery.

burn concavo-convex shape of the donor site coverage rate expansion rate meshed skin grafts

Journal

Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070

Informations de publication

Date de publication:
11 2020
Historique:
received: 07 08 2020
revised: 20 09 2020
accepted: 03 10 2020
pubmed: 11 10 2020
medline: 15 5 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

Meshed skin grafting is a common technique in operations to minimize surgery on the donor site area. However, the donor site area is empirically determined by surgeons due to the lack of a reliable formula to calculate the donor area required to cover a skin defect. To determine the minimal size for donor skin, the expansion rates of 1.5:1, 3:1, and 6:1 meshed skin graft and the area actually covered by them were investigated in real-world operations. About 51 patients who received 57 operations with meshed skin grafts were enrolled in this study. The average clinical coverage rates of area in cases in which 1.5:1, 3:1, or 6:1 meshed skin grafting was performed were 1.02, 1.29, or 2.18, respectively. Those rates were notably low when recipient sites were concave. The average expansion rates of 1.5:1, 3:1, and 6:1 meshed skin grafts were about 1.16, 1.61, and 2.32, respectively. These results indicate that the size of donor skin should be about 85%, 60%, and 45% size of the recipient site to achieve the target 1.5:1, 3:1, and 6:1 meshed skin graft, respectively. In addition, the donor area should be adjusted in consideration of the shape of the recipient sites.

Identifiants

pubmed: 33037725
doi: 10.1111/dth.14393
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14393

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Peeters R, Hubens A. The mesh skin graft-true expansion rate. Burns Incl Therm Inj. 1988;14:239-240.
Kamolz LP, Schintler M, Parvizi D, Selig H, Lumenta DB. The real expansion rate of meshers and micrografts: things we should keep in mind. Ann Burns Fire Disasters. 2013;26:26-29.
Lumenta DB, Kamolz LP, Keck M, Frey M. Comparison of meshed versus MEEK micrografted skin expansion rate: claimed, achieved, and polled results. Plast Reconstr Surg. 2011;128:40e-41e.
Matsumura H, Matsushima A, Ueyama M, Kumagai N. Application of the cultured epidermal autograft "JACE(®") for treatment of severe burns: results of a 6-year multicenter surveillance in Japan. Burns. 2016;42:769-776.

Auteurs

Takanobu Kan (T)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Shunsuke Takahagi (S)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Mikio Kawai (M)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Shinichi Ashizawa (S)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Daiki Matsubara (D)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Hayato Mizuno (H)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Akio Tanaka (A)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Michihiro Hide (M)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH